Tag: GlaxoSmithKline
GlaxoSmithKline jumps into myeloma with ‘homemade’ anti-BCMA drug Blenrep
Back in 2015, GlaxoSmithKline traded away its marketed cancer assets and began building its oncology pipeline “pretty aggressively,” as Axel Hoos, the company’s SVP...
GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple...
GlaxoSmithKline has penned deals offering its pandemic vaccine adjuvant to several developers of COVID-19 shots. And it needs to amp up supply for those...
GlaxoSmithKline taps Publicis—and its ‘platformGSK’ setup—for $1.5B media account
GlaxoSmithKline awarded its estimated $1.5 billion media planning and buying account to Publicis Media after a five-month review. Publicis will create a custom “platformGSK”...
